-
-
-
-
-
-
-
Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 1c ; Offers Guidance
-
-
-
-
-
-
-
Xeris Biopharma Reports Record First Quarter 2025 Financial ResultsĀ
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 2c, provides guidance
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Misses Q1 EPS by 4c, provides guidance
-
-
-
-
-
-
-
Xeris Biopharma Updates Its Outlook for 2023
-
-
-
-
-
-
-
Xeris Biopharma to Report Second Quarter 2023 Financial Results on August 8, 2023
-
1,199,636 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

